ALPS Advisors »

Silverback Therapeutics shares owned by ALPS Advisors

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by ALPS Advisors from 13F filings

Historical chart of ALPS Advisors investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by ALPS Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by ALPS Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $364k 66k 5.48
2023-09-30 $267k 71k 3.78
2023-06-30 $467k 70k 6.70